A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab.

Joseph MikhaelKarim Belhadj-MerzougCyrille HulinLaure VincentPhilippe MoreauCristina GasparettoLudek PourIvan SpickaRavi VijJeffrey ZonderDjordje AtanackovicNashat GabrailThomas G MartinAurore PerrotSamira BensfiaQilong WengClaire BrillacDorothée SemiondSandrine MacéKathryn P CorzoXavier Leleu

Published in: Blood cancer journal (2021)

Keyphrases

multiple myeloma
open label
combination therapy
clinical trial
study protocol
double blind
placebo controlled